SINTX TECHNOLOGIES ANNOUNCES ENGAGEMENT OF ASCENDIANT CAPITAL TO PURSUE DENTAL PARTNERSHIPS
September 11 2019 - 7:00AM
SINTX Technologies, Inc. (NASDAQ: SINT) (the “Company”), an OEM
ceramics company that develops and commercializes silicon nitride
for medical and non-medical applications, today announced that it
has retained Ascendiant Capital Markets, LLC of Irvine, California,
Member FINRA & SIPC (“Ascendiant Capital”), as investment bank
and advisor, to identify strategic opportunities in the dental
space.
“While we have been working closely with dental
implant companies in specific development projects, Ascendiant
Capital will play a critical role in disseminating our R&D
advancements to a wider audience of partners, and helping
commercialize the technology,” stated Dr. Sonny Bal, President and
CEO of SINTX. “We are excited to represent SINTX Technologies,
having deep experience and knowledge of dental companies
worldwide,” said Dr. Christopher Gayde, a former practicing dentist
and Managing Director of Ascendiant Capital’s Dental Investment
Banking Group.
Over the last nine months, SINTX has made
further advancements in its portfolio of dental technologies,
beyond the manufacturing and development of dental implants made
from its silicon nitride. The marked expansion in opportunity –
which is backed up by successful testing – encouraged SINTX to
engage Ascendiant Capital to pursue a wide range of potential
partnerships.
The new technologies include extensive work on
zirconia dental implants, and the 3-D laser surface
functionalization of both titanium metal, and zirconia ceramics
used to make modern dental implants. “With these new technologies,
all of the desirable attributes of silicon nitride can be applied
to other, proven materials that are used to make structural dental
implants. The two key properties that differentiate silicon nitride
are surface resistance to oral bacteria, and enhanced biologic
fixation to bone; both of which have been corroborated by testing
done at SINTX, and by multiple, independent outside partners,” said
Dr. Bal.
About SINTX Corporation
SINTX Technologies is an OEM ceramics company
that develops and commercializes silicon nitride for medical and
non-medical applications. The core strength of SINTX Technologies
is the manufacturing, research, and development of silicon nitride
ceramics for external partners. The Company presently manufactures
silicon nitride spinal implants in its ISO 13485 certified
manufacturing facility for CTL-Amedica, the exclusive retail
channel for silicon nitride spinal implants.
For more information on SINTX
Technologies or its silicon nitride material platform, please visit
www.sintx.com.
Forward-Looking Statements
This press release contains forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995 (“PSLRA”) that are subject to a number of risks
and uncertainties. Readers are cautioned not to place undue
reliance on the forward-looking statements, which speak only as of
the date on which they are made and reflect management’s current
estimates, projections, expectations and beliefs. There can be no
assurance that any of the anticipated results will occur on a
timely basis or at all due to certain risks and uncertainties, a
discussion of which can be found in SINTX’s Risk Factors disclosure
in its Annual Report on Form 10-K, filed with the Securities and
Exchange Commission (SEC) on March 11, 2019, and in SINTX’s other
filings with the SEC. SINTX disclaims any obligation to update any
forward-looking statements. SINTX undertakes no obligation to
publicly revise or update the forward-looking statements to reflect
events or circumstances that arise after the date of this
report.
This press release is for informational
purposes only and does not constitute a solicitation or offer to
buy or sell any securities or other financial
instrument.
Contact:SINTX Technologies
801.839.3502IR@sintx.com
SiNtx Technologies (NASDAQ:SINT)
Historical Stock Chart
From Mar 2024 to Apr 2024
SiNtx Technologies (NASDAQ:SINT)
Historical Stock Chart
From Apr 2023 to Apr 2024